Roger D. Blevins

1.1k total citations
21 papers, 879 citations indexed

About

Roger D. Blevins is a scholar working on Cardiology and Cardiovascular Medicine, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Roger D. Blevins has authored 21 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 5 papers in Pediatrics, Perinatology and Child Health and 3 papers in Surgery. Recurrent topics in Roger D. Blevins's work include Cardiac electrophysiology and arrhythmias (8 papers), Cardiac Arrhythmias and Treatments (7 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Roger D. Blevins is often cited by papers focused on Cardiac electrophysiology and arrhythmias (8 papers), Cardiac Arrhythmias and Treatments (7 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Roger D. Blevins collaborates with scholars based in United States and Argentina. Roger D. Blevins's co-authors include Melvyn Rubenfire, Massoud A. Leesar, Robert M. Califf, Paul R. Eisenberg, Kevin F. Browne, Christopher B. Granger, Joseph Puma, Raymond J. Gibbons, Alejandro Barbagelata and Marcelo F. DiCarli and has published in prestigious journals such as Journal of the American College of Cardiology, Radiology and CHEST Journal.

In The Last Decade

Roger D. Blevins

21 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger D. Blevins United States 12 516 256 182 179 146 21 879
Chang‐Her Tsai Taiwan 17 401 0.8× 257 1.0× 72 0.4× 144 0.8× 287 2.0× 36 1.0k
Carlos E. Harrison United States 17 440 0.9× 145 0.6× 119 0.7× 86 0.5× 221 1.5× 48 890
Alessandro Pardini Italy 11 462 0.9× 244 1.0× 107 0.6× 83 0.5× 345 2.4× 21 895
Joseph Puma United States 11 582 1.1× 242 0.9× 312 1.7× 164 0.9× 423 2.9× 31 1.2k
Mary Lee Myers Canada 21 722 1.4× 597 2.3× 275 1.5× 351 2.0× 383 2.6× 40 1.7k
Richard D. Weisel Canada 12 342 0.7× 361 1.4× 52 0.3× 201 1.1× 254 1.7× 13 763
Harper K. Hellems United States 17 462 0.9× 174 0.7× 157 0.9× 66 0.4× 108 0.7× 35 939
Geoffrey Berg United Kingdom 18 524 1.0× 102 0.4× 69 0.4× 57 0.3× 456 3.1× 55 1.2k
Enrico Mangieri Italy 20 898 1.7× 100 0.4× 356 2.0× 48 0.3× 327 2.2× 69 1.5k
J. Bouthier France 15 446 0.9× 60 0.2× 66 0.4× 46 0.3× 188 1.3× 27 680

Countries citing papers authored by Roger D. Blevins

Since Specialization
Citations

This map shows the geographic impact of Roger D. Blevins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger D. Blevins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger D. Blevins more than expected).

Fields of papers citing papers by Roger D. Blevins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger D. Blevins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger D. Blevins. The network helps show where Roger D. Blevins may publish in the future.

Co-authorship network of co-authors of Roger D. Blevins

This figure shows the co-authorship network connecting the top 25 collaborators of Roger D. Blevins. A scholar is included among the top collaborators of Roger D. Blevins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger D. Blevins. Roger D. Blevins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahaffey, Kenneth W., Joseph Puma, Alejandro Barbagelata, et al.. (1999). Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction. Journal of the American College of Cardiology. 34(6). 1711–1720. 412 indexed citations
2.
Levinson, Stanley S., et al.. (1989). The Relationship Between Apolipoprotein B-100 and Low-Density Lipoprotein Cholesterol after Treatment with an HMG CoA Reductase Inhibitor. American Journal of Clinical Pathology. 92(4). 479–483. 4 indexed citations
3.
Blevins, Roger D., et al.. (1989). Dopamine and Dobutamine Induce Hypokalemia in Anesthetized Dogs. Journal of Cardiovascular Pharmacology. 13(4). 662–666. 1 indexed citations
4.
Kerin, Nicholas Z., et al.. (1988). Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone.. PubMed. 11(3 Suppl 2). II31–40. 13 indexed citations
5.
Kerin, Nicholas Z., et al.. (1988). A Low Incidence of Proarrhythmia Using Low‐Dose Amiodarone. 2(4). 289–295. 8 indexed citations
6.
Blevins, Roger D., et al.. (1987). The prognostic value of functional capacity in patients with mild to moderate heart failure. American Heart Journal. 114(2). 377–382. 40 indexed citations
7.
Maciejko, James J., et al.. (1987). New assay of apolipoproteins A-I and B by rate nephelometry evaluated.. Clinical Chemistry. 33(11). 2065–2069. 80 indexed citations
8.
Kerin, Nicholas Z., et al.. (1987). Coronary vasospasm as a cause of stunned myocardium. American Heart Journal. 113(2). 383–385. 46 indexed citations
9.
Blevins, Roger D.. (1987). Amiodarone in the Management of Refractory Atrial Fibrillation. Archives of Internal Medicine. 147(8). 1401–1401. 68 indexed citations
10.
Edwards, David J., et al.. (1987). The effect of coadministration of verapamil on the pharmacokinetics and metabolism of quinidine. Clinical Pharmacology & Therapeutics. 41(1). 68–73. 35 indexed citations
11.
Bach, D., et al.. (1986). The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.. British Journal of Clinical Pharmacology. 21(6). 655–659. 25 indexed citations
12.
Kerin, Nicholas Z., et al.. (1986). Relation of serum reverse T3 to amiodarone antiarrhythmic efficacy and toxicity. The American Journal of Cardiology. 57(1). 128–130. 17 indexed citations
13.
Rubenfire, Melvyn, et al.. (1986). Platelet hyperaggregability in patients with chest pain and angiographically normal coronary arteries. The American Journal of Cardiology. 57(8). 657–660. 45 indexed citations
14.
Blevins, Roger D., et al.. (1986). Intravenous lorcainide versus lidocaine in the treatment of frequent and complex ventricular arrhythmias. American Heart Journal. 111(3). 447–451. 4 indexed citations
15.
Blevins, Roger D., et al.. (1986). Arrhythmia control and other factors related to sudden death in coronary disease patients at intermediate risk. American Heart Journal. 111(4). 638–644. 9 indexed citations
16.
Kerin, Nicholas Z., et al.. (1985). Intravenous and oral loading versus oral loading alone with amiodarone for chronic refractory ventricular arrhythmias. The American Journal of Cardiology. 55(1). 89–91. 28 indexed citations
17.
Rubenfire, Melvyn, et al.. (1984). The systemic fibrinolytic effect of low-dose intraarterial streptokinase: observations in 12 patients. Work in progress.. Radiology. 152(1). 41–43. 5 indexed citations
18.
Blevins, Roger D., et al.. (1984). Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrobial Agents and Chemotherapy. 25(5). 603–606. 29 indexed citations
19.
Kerin, Nicholas Z., et al.. (1983). Acute Thrombophlebitis following IV Amiodarone Administration. CHEST Journal. 84(1). 120–120. 3 indexed citations
20.
Bockbrader, Howard N., et al.. (1980). The effect of peritoneal dialysis of the pharmacokinetics of amikacin.. PubMed. 10. 302–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chang‐Her Tsai Breakdown of academic impact, for papers by Carlos E. Harrison Breakdown of academic impact, for papers by Alessandro Pardini Breakdown of academic impact, for papers by Joseph Puma Breakdown of academic impact, for papers by Mary Lee Myers Breakdown of academic impact, for papers by Richard D. Weisel Breakdown of academic impact, for papers by Harper K. Hellems Breakdown of academic impact, for papers by Geoffrey Berg Breakdown of academic impact, for papers by Enrico Mangieri Breakdown of academic impact, for papers by J. Bouthier
Rankless by CCL
2026